News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel Rejects Merck & Co., Inc. (MRK) Respiratory Pill Singulair For Over-The-Counter Use


5/5/2014 8:10:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Federal health advisers have voted against a Merck proposal to sell its prescription respiratory pill Singulair as an over-the-counter allergy medication. The Food and Drug Administration's panel of experts voted 11-4 today against making the drug available without a prescription. Merck sells Singulair via prescription for asthma and allergies. Singulair was once Merck's best-selling drug, but sales have plummeted since the drug's patent expired in mid-2012, exposing the brand to low cost generics.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at nj.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES